142 related articles for article (PubMed ID: 9861280)
1. A multi-centre study of the effect of Mectizan treatment on onchocercal skin disease: clinical findings.
Ogbuagu KF; Eneanya CI
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S139-45. PubMed ID: 9861280
[TBL] [Abstract][Full Text] [Related]
2. The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial.
Brieger WR; Awedoba AK; Eneanya CI; Hagan M; Ogbuagu KF; Okello DO; Ososanya OO; Ovuga EB; Noma M; Kale OO; Burnham GM; Remme JH
Trop Med Int Health; 1998 Dec; 3(12):951-61. PubMed ID: 9892280
[TBL] [Abstract][Full Text] [Related]
3. The African Programme for Onchocerciasis Control: impact on onchocercal skin disease.
Ozoh GA; Murdoch ME; Bissek AC; Hagan M; Ogbuagu K; Shamad M; Braide EI; Boussinesq M; Noma MM; Murdoch IE; Sékétéli A; Amazigo UV
Trop Med Int Health; 2011 Jul; 16(7):875-83. PubMed ID: 21481109
[TBL] [Abstract][Full Text] [Related]
4. Control of onchocerciasis.
Boatin BA; Richards FO
Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
[TBL] [Abstract][Full Text] [Related]
5. Onchocerciasis in Anambra State, Southeast Nigeria: clinical and psychological aspects and sustainability of community directed treatment with ivermectin (CDTI).
Mbanefo EC; Eneanya CI; Nwaorgu OC; Oguoma VM; Otiji MO; Ogolo BA
Postgrad Med J; 2010 Oct; 86(1020):573-7. PubMed ID: 20971709
[TBL] [Abstract][Full Text] [Related]
6. The effect of 5 years of annual treatment with ivermectin (Mectizan) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic.
Kennedy MH; Bertocchi I; Hopkins AD; Meredith SE
Ann Trop Med Parasitol; 2002 Apr; 96(3):297-307. PubMed ID: 12061976
[TBL] [Abstract][Full Text] [Related]
7. [Onchodermatitis (sowda) in patients in Yémen. Clinical and histologic course after treatment with ivermectin].
al Qubati Y; Reynouard F; Kumar F; Gaxotte P; Richard-Lenoble D
Sante; 1997; 7(6):391-5. PubMed ID: 9503497
[TBL] [Abstract][Full Text] [Related]
8. Special intervention zones.
Yaméogo L
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():23-4. PubMed ID: 18718150
[TBL] [Abstract][Full Text] [Related]
9. The varied beneficial effects of ivermectin (Mectizan) treatment, as observed within onchocerciasis foci in south-eastern Nigeria.
Anosike JC; Dozie IN; Ameh GI; Ukaga CN; Nwoke BE; Nzechukwu CT; Udujih OS; Nwosu DC
Ann Trop Med Parasitol; 2007 Oct; 101(7):593-600. PubMed ID: 17877878
[TBL] [Abstract][Full Text] [Related]
10. Onchocercal eye disease and the impact of Mectizan treatment.
Abiose A
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S11-22. PubMed ID: 9861263
[TBL] [Abstract][Full Text] [Related]
11. Development of reactive onchocercal skin lesions during a placebo-controlled trial with ivermectin among persons without lesions at baseline.
Brieger WR; Kale OO; Ososanya OO
Trop Doct; 2001 Apr; 31(2):96-8. PubMed ID: 11321284
[TBL] [Abstract][Full Text] [Related]
12. Reversal of amenorrhoea after Mectizan treatment.
Anosike JC; Abanobi OC
Trop Geogr Med; 1995; 47(5):222-4. PubMed ID: 8553449
[TBL] [Abstract][Full Text] [Related]
13. Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin.
Shu EN; Nwadike KI; Onwujekwe EO; Ugwu OC; Okonkwo PO
East Afr Med J; 1999 Jun; 76(6):320-3. PubMed ID: 10750518
[TBL] [Abstract][Full Text] [Related]
14. Effect of repeated community-based ivermectin treatment on the intensity of onchocerciasis in Nigeria.
Oyibo WA; Fagbenro-Beyioku AF
Rural Remote Health; 2003; 3(2):211. PubMed ID: 15877511
[TBL] [Abstract][Full Text] [Related]
15. The delivery of ivermectin (Mectizan).
Burnham G; Mebrahtu T
Trop Med Int Health; 2004 Apr; 9(4):A26-44. PubMed ID: 15078277
[TBL] [Abstract][Full Text] [Related]
16. [Human onchocerciasis and "sowda" in the Republic of Yemen].
Richard-Lenoble D; al Qubati Y; Toe L; Pisella PJ; Gaxotte P; al Kohlani A
Bull Acad Natl Med; 2001; 185(8):1447-59; discussion 1459-61. PubMed ID: 11974966
[TBL] [Abstract][Full Text] [Related]
17. DISTRIBUTION AND UTILISATION OF IVERMECTIN (MECTIZAN): A CHEMOTHERAPEUTIC APPROACH TO THE CONTROL OF ONCHOCERCIASIS IN OLD OHAOZARA LGA, EBONYI STATE, EASTERN NIGERIA.
Okpara EM; Mnaemeka AM; Iyioku UU; Udoh UV
J Egypt Soc Parasitol; 2015 Dec; 45(3):663-70. PubMed ID: 26939245
[TBL] [Abstract][Full Text] [Related]
18. Ivermectin--clinical trials and treatment schedules in onchocerciasis.
Brown KR; Neu DC
Acta Leiden; 1990; 59(1-2):169-75. PubMed ID: 2198749
[TBL] [Abstract][Full Text] [Related]
19. Impact of 3 years ivermectin treatment on onchocerciasis in Yanomami communities in the Brazilian Amazon.
Banic DM; Calvão-Brito RH; Marchon-Silva V; Schuertez JC; de Lima Pinheiro LR; da Costa Alves M; Têva A; Maia-Herzog M
Acta Trop; 2009 Nov; 112(2):125-30. PubMed ID: 19615327
[TBL] [Abstract][Full Text] [Related]
20. New light shed on the importance and care of onchocercal skin disease.
TDR News; 1998 Feb; (55):5. PubMed ID: 12348563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]